Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Arthritis Rheumatol. 2019 Nov 1;71(12):2059–2067. doi: 10.1002/art.41020

Table 2.

Baseline correlations between KL-6 and CCL-18 and SSc disease activity measures

Disease measure KL-6-SLS II (N = 133) CCL-18-SLS II (N = 133)
FVC%-predicted −0.01 0.11
DLCO%-predicted −0.23*** −0.04
TLC%-predicted −0.21*** 0.01
QILD-WL 0.35*** 0.14*
QILD-ZM 0.35*** 0.18**
QLF-WL 0.36*** 0.08
QLF-ZM 0.33*** 0.10
*

p < 0.05;

**

p < 0.01;

***

p < 0.001